Two Sigma Investments, LP Biomarin Pharmaceutical Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 299,531 shares of BMRN stock, worth $19 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

299,531

Previous 83,500 258.72%

Holding current value

$19 Million

Previous $6.87 Million 206.28%

% of portfolio

0.05%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $2.82 Million - $3.84 Million	-40,919 Reduced 12.02%	299,531 $21.1 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $26.8 Million - $33.2 Million	-360,049 Reduced 51.4%	340,450 $28 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $24 Million - $28.4 Million	286,534 Added 69.22%	700,499 $61.2 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $7.62 Million - $9.85 Million	-100,033 Reduced 19.46%	413,965 $39.9 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $7.21 Million - $8.01 Million	84,810 Added 19.76%	513,998 $45.5 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $36.5 Million - $42.3 Million	-421,626 Reduced 49.56%	429,188 $37.2 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $7.41 Million - $9.9 Million	84,442 Added 11.02%	850,814 $82.7 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $27.2 Million - $36.5 Million	336,437 Added 78.25%	766,372 $79.3 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $26.9 Million - $31.8 Million	327,581 Added 320.05%	429,935 $36.4 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $16.2 Million - $19.6 Million	-226,236 Reduced 68.85%	102,354 $8.48 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $2.43 Million - $3.04 Million	-32,761 Reduced 9.07%	328,590 $25.3 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $19.2 Million - $24.5 Million	267,425 Added 284.72%	361,351 $31.9 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $493,482 - $564,102	-6,600 Reduced 6.57%	93,926 $7.26 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $2.79 Million - $3.13 Million	36,890 Added 57.97%	100,526 $8.39 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $9.8 Million - $13.3 Million	-137,252 Reduced 68.32%	63,636 $5.38 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $34.6 Million - $46.5 Million	-538,012 Reduced 72.81%	200,888 $17 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $17.2 Million - $21.7 Million	255,449 Added 52.84%	738,900 $49.8 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $27 Million - $31.6 Million	336,068 Added 228.02%	483,451 $41.4 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $10.6 Million - $12.4 Million	126,018 Added 589.83%	147,383 $13.1 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $1.51 Million - $2 Million	18,849 Added 749.17%	21,365 $1.82 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $236,302 - $265,991	2,516 New	2,516 $244,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Biomarin Pharmaceutical Inc Transaction History